MLYS- Mineralys Therapeutics, Inc.

Name: Mineralys Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Mineralys Therapeutics, Inc. (MLYS) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. MLYS is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Slingsby Brian Taylor	7.90M	$233.48M	-
Dir	Ra Capital Management, L.P.	5.46M	$161.19M	-
CEO	Congleton Jon	689.3K	$20.36M	-15,730
Dir	Akkaraju Srinivas	588.2K	$17.38M	-
Other	Rodman David Malcom	69.8K	$2.06M	-20,822

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 17, 2026	Rodman David Malcom58	Chief Medical Officer	Sale+OE	416	$31.33	$13,033.28	-0.6%	-	-
Apr 15, 2026	Rodman David Malcom58	Chief Medical Officer	Sale+OE	20,406	$26.89	$548,672.35	-12.3%	-	-
Apr 13, 2026	Congleton Jon47	Chief Executive Officer	Sell	15,730	$26.83	$421,979.27	-2.2%	-	-
Apr 9, 2026	Rodman David Malcom58	Chief Medical Officer	Sale+OE	2,170	$27.38	$59,414.60	-2.8%	-	-
Mar 13, 2026	Rodman David Malcom58	Chief Medical Officer	Sale+OE	20,406	$26.61	$542,973.39	-6.1%	-	-
Jan 14, 2026	Rodman David Malcom58	Chief Medical Officer	Sale+OE	19,076	$32.66	$623,114.66	-14.5%	-20.3%	-
Jan 12, 2026	Congleton Jon47	Chief Executive Officer	Sell	16,236	$32.62	$529,639.60	-1.2%	-19.3%	-
Jan 12, 2026	Levy Adam Scott	CFO And Secretary	Sell	10,758	$32.14	$345,723.39	-55.5%	-19.3%	-
Jan 12, 2026	Rodman David Malcom58	Chief Medical Officer	Sale+OE	8,518	$32.56	$277,339.14	-6.4%	-19.3%	-
Jan 5, 2026	Rodman David Malcom58	Chief Medical Officer	Sale+OE	262,752	$35.25	$9,261,028.10	-51.6%	-20.8%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC